We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Raps MasterPharm for Multiple GMP Violations
The FDA cited MasterPharm following an inspection of its South Richmond Hill, N.Y. plant that revealed numerous violations of current good manufacturing practices.